Navigation Links
Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
Date:4/30/2008

Leading Developer of Antibody Technologies to Strengthen Management Team

WEST BEND, Wis., April 30 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink sheets: MNCN), a manufacturer and distributor of products for animal health, announced today the appointment of Dr. Peter C. Nash, Ph.D. as Chief Scientific Officer.

In his new role, Dr. Nash will be responsible for spearheading Mach One's development activities in innovative antibody technologies for use in the dairy, beef, poultry, and swine markets.

Dr. Nash is a microbiologist with over 30 years of experience in 13 areas of medicine, from parasitology to immunology to virology. He has been a professor at the Indiana School of Medicine, University of Minnesota and Minnesota State University, Mankato. Throughout the past 25 years he was involved in a variety of roles researching and developing rapid human diagnostics to agriculture -- researching Campylobacter, Pasteurella and E. coli 0157:H7. Dr. Nash developed quick swab tests to detect Listeria in feedlots and E. coli in processing plants. Dr. Nash also developed tests for strep, whooping cough, salmonella, toxins and other diagnostics. During the first Gulf War, he worked on anthrax tests until government funding dissipated. Along with two others, Dr. Nash spun off Camas Inc. From the University Technical Center in Minneapolis, they expanded their work and under the direction of Dr. Nash, Camas did work for the U.S. Department of Defense, the U.S. Marine Corps, and the U.S.D.A. After nearly three decades of microbial study, Dr. Nash designed all-natural cattle feed additives to inhibit a dangerous E. coli 1057:H7 strain and improve feed efficiency with "impressive results." Dr. Nash holds three patents as a result of his work and has many international patents pending.

Announcing the appointment, Monte Tobin, CEO, said, "Peter brings with him a combination of both research and scientific applications experience in antibody production for animal use which will help commercially expand our unique product set for distribution into our targeted animal markets."

On his new appointment, Dr. Nash said, "This is an exciting opportunity for me to join one of the most creative organizations in this field. The company's recent work and stated direction into this highly profitable, yet underserved market, will allow me to continue my research and development of new and efficient ways to use antibodies to strengthen the health of all animals intended for human consumption."

About Mach One Corporation

Through its wholly-owned subsidiary VDx, Inc. ( http://www.vdxinc.com ), the company currently manufactures and sells Immunogam (TM) , a colostrums replacement, supplement and prophylactic, in sterile powder form, which can be administered orally or intravenously. VDx is also further developing a proprietary procedure to allow for large scale manufacturing of colostral replacement products for market that includes an added ingredient for elimination of mastitis and Johnnes disease.

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.


'/>"/>
SOURCE Mach One Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters
2. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
3. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
4. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
5. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
6. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
7. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
8. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
9. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):